Transcriptomics

Dataset Information

0

RNAseq to investigate transcriptional changes in human MM cell lines due to panobinostat, 5-Azacytidine, panobinostat+5-Azacytidine or n-methyl-2-pyrroldine (NMP) treatments.


ABSTRACT: Purpose: We applied RNA sequencing technology for high-throughput analysis of transcriptional changes within human MM cell lines JJN3 and U266 due to individual and combination drug treatment. Methods: JJN3 and U266 cells were treated with pan-HDACi panbobinostat, DNMTi 5-Azacytidine, panobinostat+5-Azacytidine or NMP for 4h or 24h in triplicate and transcriptional changes assessed by RNAseq using Illumina HiSeq platform. Specifically, JJN3 cells were treated with 10nM panobinostat, 2.5µM 5-Azacytidine, panobinostat+5-Azacytidine (at given doses), or 10mM NMP. U266 cells were treated with 10nM panobinostat, 10µM 5-Azacytidine, panobinostat+5-Azacytidine (at given doses), or 10mM NMP. Results: We report unique and overlapping transcriptional signatures that lead to the induction of apoptosis in human MM cell lines in a cell-specific manner due to individual or combination treatments. Conclusions: A detailed analysis of differential transcriptional events in human MM cell lines due to HDACi, DNMTi, HDACi+DNMTi and NMP appear to define the molecular events leading to apoptosis and drug mechanism of action.

ORGANISM(S): Homo sapiens

PROVIDER: GSE56623 | GEO | 2014/04/09

SECONDARY ACCESSION(S): PRJNA244098

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2014-04-09 | E-GEOD-56623 | biostudies-arrayexpress
2015-06-02 | GSE69410 | GEO
2016-03-01 | E-GEOD-76664 | biostudies-arrayexpress
2024-09-08 | GSE276501 | GEO
2017-07-01 | GSE83983 | GEO
2016-03-01 | GSE76664 | GEO
2018-01-30 | GSE109792 | GEO
2017-09-01 | GSE102757 | GEO
2015-04-29 | E-GEOD-57130 | biostudies-arrayexpress
2015-12-31 | E-GEOD-68690 | biostudies-arrayexpress